(-0.43%) 5 027.50 points
(-0.33%) 37 883 points
(-0.68%) 17 428 points
(0.58%) $83.21
(-0.91%) $1.741
(0.07%) $2 399.60
(0.16%) $28.43
(-0.48%) $949.90
(-0.05%) $0.939
(-0.03%) $11.04
(-0.05%) $0.804
(-0.62%) $93.32
-2.36% KRW 99 200
Live Chart Being Loaded With Signals
Chong Kun Dang pharmaceutical Corp. engages in the manufacturing, marketing, and selling of medicines in South Korea and internationally. It provides prescription drugs for anti-hypertension, anti-hyperlipidemia, and anti-diabetics; over-the-counter drugs, such as Penzal, Prefemine, and Modcol, as well as consumer health products, such as insecticides, hair dye, etc...
Stats | |
---|---|
Today's Volume | 44 038.00 |
Average Volume | 44 006.00 |
Market Cap | 1 260.10B |
EPS | KRW0 ( 2024-02-06 ) |
Next earnings date | ( KRW1 831.50 ) 2024-05-12 |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW92.31 (0.09%) |
Volume Correlation
Chong Kun Dang Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Chong Kun Dang Correlation - Currency/Commodity
Chong Kun Dang Financials
Annual | 2023 |
Revenue: | KRW1 669.40B |
Gross Profit: | KRW655.34B (39.26 %) |
EPS: | KRW16 704 |
Q4 | 2023 |
Revenue: | KRW504.61B |
Gross Profit: | KRW230.85B (45.75 %) |
EPS: | KRW6 935.42 |
Q3 | 2023 |
Revenue: | KRW403.61B |
Gross Profit: | KRW149.82B (37.12 %) |
EPS: | KRW3 575.97 |
Q2 | 2023 |
Revenue: | KRW396.01B |
Gross Profit: | KRW144.35B (36.45 %) |
EPS: | KRW3 355.23 |
Financial Reports:
No articles found.
Chong Kun Dang
Chong Kun Dang pharmaceutical Corp. engages in the manufacturing, marketing, and selling of medicines in South Korea and internationally. It provides prescription drugs for anti-hypertension, anti-hyperlipidemia, and anti-diabetics; over-the-counter drugs, such as Penzal, Prefemine, and Modcol, as well as consumer health products, such as insecticides, hair dye, etc.; and healthcare supplements with preventive benefits. The company also exports its products. Chong Kun Dang pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators